Created at	Source	Raw Value	Validated value
Jan. 20, 2023, 8 a.m.	usa	Incidence of actively detected local and systemic AEs (Stage I);Incidence of actively detected local and systemic AEs (Stage II);Increase in geometric mean titers of antibodies to N-protein of SARS-CoV-2 (Stage II)	Incidence of actively detected local and systemic AEs (Stage I);Incidence of actively detected local and systemic AEs (Stage II);Increase in geometric mean titers of antibodies to N-protein of SARS-CoV-2 (Stage II)
Dec. 16, 2021, 2 a.m.	usa	Primary endpoint (Stage I);Primary endpoint (Stage II)	Primary endpoint (Stage I);Primary endpoint (Stage II)